Evidence map›Paper›PMID 37175677›Full record

ArticleInternational journal of molecular sciences2023

Extracellular Vesicles Isolation from Large Volume Samples Using a Polydimethylsiloxane-Free Microfluidic Device.

Cristina Bajo-Santos, Miks Priedols, Pauls Kaukis, Gunita Paidere, Romualds Gerulis-Bergmanis, Gatis Mozolevskis, Arturs Abols, Roberts Rimsa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cristina Bajo-SantosLatvian Biomedical Research and Study Centre, Ratsupites Str. 1, k-1, LV-1067 Riga, Latvia.ORCID 0000-0002-2694-7572
Miks PriedolsLatvian Biomedical Research and Study Centre, Ratsupites Str. 1, k-1, LV-1067 Riga, Latvia.
Pauls KaukisLatvian Biomedical Research and Study Centre, Ratsupites Str. 1, k-1, LV-1067 Riga, Latvia.
Gunita PaidereInstitute of Solid-State Physics, University of Latvia, 8 Kengaraga Str., LV-1063 Riga, Latvia.
Romualds Gerulis-BergmanisLatvian Biomedical Research and Study Centre, Ratsupites Str. 1, k-1, LV-1067 Riga, Latvia.
Gatis MozolevskisInstitute of Solid-State Physics, University of Latvia, 8 Kengaraga Str., LV-1063 Riga, Latvia.
Arturs AbolsLatvian Biomedical Research and Study Centre, Ratsupites Str. 1, k-1, LV-1067 Riga, Latvia.
Roberts RimsaInstitute of Solid-State Physics, University of Latvia, 8 Kengaraga Str., LV-1063 Riga, Latvia.ORCID 0000-0002-8915-5361
Latvian Biomedical Research and Study Centre · LVUniversity of Latvia · LV

Funding

Latvian Council of Science LZP-2019/1-0142.
6 · The paper itself

Abstract

Extracellular vesicles (EV) have many attributes important for biomedicine; however, current EV isolation methods require long multi-step protocols that generally involve bulky equipment that cannot be easily translated to clinics. Our aim was to design a new cyclic olefin copolymer-off-stoichiometry thiol-ene (COC-OSTE) asymmetric flow field fractionation microfluidic device that could isolate EV from high-volume samples in a simple and efficient manner. We tested the device with large volumes of urine and conditioned cell media samples, and compared it with the two most commonly used EV isolation methods. Our device was able to separate particles by size and buoyancy, and the attained size distribution was significantly smaller than other methods. This would allow for targeting EV size fractions of interest in the future. However, the results were sample dependent, with some samples showing significant improvement over the current EV separation methods. We present a novel design for a COC-OSTE microfluidic device, based on bifurcating asymmetric flow field-flow fractionation (A4F) technology, which is able to isolate EV from large volume samples in a simple, continuous-flow manner. Its potential to be mass-manufactured increases the chances of implementing EV isolation in a clinical or industry-friendly setting, which requires high repeatability and throughput.

Indexed as

Extracellular VesiclesFractionation, Field FlowChemical FractionationCulture Media, ConditionedDimethylpolysiloxanesLab-On-A-Chip DevicesPolymersbaysilonCulture Media, ConditionedDimethylpolysiloxanesPolymersA4Fextracellular vesiclesmicrofluidic devicesOSTE–COCPDMS-freeseparationurine

Identifiers

PMID37175677
PMCPMC10178709
OpenAlexW4367317554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.